In the Media
Are you looking for the latest media coverage of the BioMed X Institute, its research projects and people behind the innovation model? Here you will find the latest clippings – hot off the press!
Visit: BioMed X Launches New T Cell Immunology Discovery Platform
BioMed X Launches New T Cell Immunology Discovery Platform
BioSpace
A new technology developed by BioMed X in collaboration with Janssen functionally identifies and validates T cell target antigens, making it a powerful tool for immunology discovery.
Visit: Novel Alliance Responds to Big Pharma’s Most Pressing AI/ML Needs
Novel Alliance Responds to Big Pharma’s Most Pressing AI/ML Needs
BioSpace
Artificial intelligence and machine learning applications are not the future of drug development; they’re already here, being deployed at large pharmaceutical companies like Pfizer and Merck KGaA.
Visit: German research institute picks New Haven for first U.S. location
German research institute picks New Haven for first U.S. location
CT Insider
An independent research institute based in Germany has chosen New Haven as its first location here in the United States.
Visit: BioMed X to establish first US-based research institute in New Haven
BioMed X to establish first US-based research institute in New Haven
New Haven Biz
BioMed X, a biomedical research institute in Germany, is launching its first U.S. facility here in New Haven. The BioMed X Institute in New Haven will focus on research in the areas of immunology and tissue engineering.
Visit: German Biomed Researchers Pick New Haven For U.S. Post
German Biomed Researchers Pick New Haven For U.S. Post
New Haven Independent
A German biomedical research institute is putting down roots in New Haven, with newly announced plans to move into a local lab space later this year as it partners with a biopharmaceutical company to study immunology and tissue engineering. That research firm is called BioMed X.
Visit: BioMed X Extends Research Collaboration With AbbVie On Immunology And Tissue Engineering
BioMed X Extends Research Collaboration With AbbVie On Immunology And Tissue Engineering
RTT News/Nasdaq
BioMed X noted that the new US-based research collaboration will focus on immunology and tissue engineering, following a first joint research project on Alzheimer’s disease at the BioMed X Institute in Heidelberg, Germany.
Visit: BioMed X establishes its first US-based institute in New Haven with a new immunology research project in collaboration with AbbVie
BioMed X establishes its first US-based institute in New Haven with a new immunology research project in collaboration with AbbVie
BioSpace
“Extending our successful partnership with AbbVie to our new site in the US is a big milestone for our institute,” said Christian Tidona, Founder and Managing Director of BioMed X.
Visit: BioMed X and AbbVie Extend Research Collaboration in the US
BioMed X and AbbVie Extend Research Collaboration in the US
PharmiWeb
BioMed X establishes its first US-based institute in New Haven with a new immunology research project in collaboration with AbbVie.
Visit: BioMed X, AbbVie extend partnership to focus on immunology research
BioMed X, AbbVie extend partnership to focus on immunology research
Seeking Alpha
BioMed X is broadening an existing partnership with AbbVie to focus on immunology and tissue engineering. BioMed X is also launching a research institute in the US based in New Haven, CT.
Visit: BioMed X and AbbVie Extend Research Collaboration in the US
BioMed X and AbbVie Extend Research Collaboration in the US
CBS19 News
BioMed X establishes its first US-based institute in New Haven with a new immunology research project in collaboration with AbbVie.
Visit: BioMed X and AbbVie Extend Research Collaboration in the US
BioMed X and AbbVie Extend Research Collaboration in the US
Yahoo! Finance
BioMed X – an independent research institute – establishes its first US-based institute in New Haven, CT, with a new immunology & tissues engineering research project in collaboration with AbbVie.
Visit: BioMed X and AbbVie Extend Research Collaboration in the US
BioMed X and AbbVie Extend Research Collaboration in the US
Street Insider
BioMed X, an independent German biomedical research institute, announced today the extension of its ongoing research collaboration with AbbVie. This marks the launch of the first BioMed X Institute in the US, to be located in New Haven, Connecticut.
Visit: BioMed X and AbbVie Extend Research Collaboration in the US
BioMed X and AbbVie Extend Research Collaboration in the US
GlobeNewswire
BioMed X establishes its first US-based institute in New Haven with a new immunology research project in collaboration with AbbVie.
Visit: BioMed X and AbbVie Extend Research Collaboration in the US
BioMed X and AbbVie Extend Research Collaboration in the US
FinanzNachrichten
BioMed X, an independent German biomedical research institute, announced today the extension of its ongoing research collaboration with AbbVie. This marks the launch of the first BioMed X Institute in the US, to be located in New Haven, Connecticut.
Visit: New Haven Biosciences Ecosystem News: BioMed X and AbbVie Extend Research Collaboration in the US
New Haven Biosciences Ecosystem News: BioMed X and AbbVie Extend Research Collaboration in the US
Yale Ventures
“Yale is devoted to academic leadership as well as global strategic partnerships to foster innovation and an entrepreneurial spirit. We welcome BioMed X to our biosciences community and appreciate the opportunities this alliance ushers in, including cooperation with international industry partners and networking with the European biotech ecosystem,” said Josh Geballe, Managing Director at Yale Ventures.
Visit: AbbVie extends partnership with Germany’s BioMed X Institute
AbbVie extends partnership with Germany’s BioMed X Institute
NS Healthcare
The extended collaboration marks the establishment of a new BioMed X Institute in the US, near the historic Yale University campus in New Haven, Connecticut, and will focus on immunology and tissue engineering.
Visit: BioMed X and AbbVie Extend Research Collaboration in the US
BioMed X and AbbVie Extend Research Collaboration in the US
Advance CT
BioMed X announced today the extension of its ongoing research collaboration with AbbVie. This marks the launch of the first BioMed X Institute in the US, to be located in New Haven, Connecticut. The new US-based research collaboration will focus on immunology and tissue engineering.
Visit: Why big pharma is reinventing itself in Israel
Why big pharma is reinventing itself in Israel
Israel21c
AstraZeneca, Merck, Pfizer and Teva partner in a consortium in Rehovot looking for Israeli ingenuity to reboot the industry.
Visit: BioMed X and Sanofi join hands to use AI for drug development
BioMed X and Sanofi join hands to use AI for drug development
LifeSci Voice
Under this research partnership, a team will be set up to focus on developing a precise computational platform to predict first-in-class drug candidates’ efficacy.
Visit: BioMed X Inks Research Collaboration With Sanofi on Artificial Intelligence for Drug Development
BioMed X Inks Research Collaboration With Sanofi on Artificial Intelligence for Drug Development
GlobeNewswire
First joint research project between Sanofi and the BioMed X Institute, co-creation of a next-generation virtual patient engine for clinical translation of drug candidates
Visit: Sanofi and BioMed X Team Up to Use AI for Drug Development
Sanofi and BioMed X Team Up to Use AI for Drug Development
Yahoo! Finance
This is the first joint research project between Sanofi and the BioMed X Institute for the co-creation of a next-generation virtual patient engine for the clinical translation of drug candidates.